ID
39315
Description
1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01303679
Link
https://clinicaltrials.gov/show/NCT01303679
Keywords
Versions (1)
- 12/18/19 12/18/19 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
December 18, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility First Line Metastatic Breast Cancer NCT01303679
Eligibility First Line Metastatic Breast Cancer NCT01303679
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Prior Adjuvant Therapy | exemestane | Prior Therapy metastatic
Data type
boolean
Alias
- UMLS CUI [1]
- C1514456
- UMLS CUI [2]
- C0851344
- UMLS CUI [3,1]
- C1514463
- UMLS CUI [3,2]
- C1522484
Description
Cemotherapeutics regimen first line of treatment | Except Paclitaxel | Except Bevacizumab
Data type
boolean
Alias
- UMLS CUI [1]
- C2045825
- UMLS CUI [2,1]
- C0332300
- UMLS CUI [2,2]
- C0144576
- UMLS CUI [3,1]
- C0332300
- UMLS CUI [3,2]
- C0796392
Description
Prior Therapy | Paclitaxel | bevacizumab
Data type
boolean
Alias
- UMLS CUI [1]
- C1514463
- UMLS CUI [2]
- C0144576
- UMLS CUI [3]
- C0796392
Description
HER2 Positive | Estrogen receptor negative
Data type
boolean
Alias
- UMLS CUI [1]
- C2348909
- UMLS CUI [2]
- C0279756
Description
Thrombosis Event Previous
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0040053
- UMLS CUI [1,2]
- C0441471
- UMLS CUI [1,3]
- C0205156
Description
Prior surgery
Data type
boolean
Alias
- UMLS CUI [1]
- C0455610
Description
Blood Coagulation Disorder Previous
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0005779
- UMLS CUI [1,2]
- C0205156
Similar models
Eligibility First Line Metastatic Breast Cancer NCT01303679
- StudyEvent: Eligibility
C3495949 (UMLS CUI [2])
C2348908 (UMLS CUI [2])
C0144576 (UMLS CUI [2])
C0796392 (UMLS CUI [3])
C0851344 (UMLS CUI [2])
C1514463 (UMLS CUI [3,1])
C1522484 (UMLS CUI [3,2])
C0332300 (UMLS CUI [2,1])
C0144576 (UMLS CUI [2,2])
C0332300 (UMLS CUI [3,1])
C0796392 (UMLS CUI [3,2])
C0144576 (UMLS CUI [2])
C0796392 (UMLS CUI [3])
C0279756 (UMLS CUI [2])
C0441471 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C0205156 (UMLS CUI [1,2])